Status:

COMPLETED

Transfusion Requirements in Orthopedic Surgery (PHASE 2)

Lead Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Conditions:

Total Hip or Knee Arthroplasty

Eligibility:

All Genders

60+ years

Brief Summary

The objective of our research program is to determine the transfusion threshold required to maximize functional recovery after major orthopedic surgery (total hip/knee replacement) in these, most ofte...

Detailed Description

Anemia is frequent after a surgical procedure. Postoperative anemia is associated with an increased incidence of transfusions and, probably, with an increased incidence of morbidity and mortality. How...

Eligibility Criteria

Inclusion

  • Patients undergoing isolated elective total hip or knee arthroplasty (primary or revision surgery for a non-malignant condition), aged 60 years or older and able to walk prior to surgery.

Exclusion

  • Since this an observational study, all patients conforming to inclusion criteria will be included.

Key Trial Info

Start Date :

May 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2011

Estimated Enrollment :

305 Patients enrolled

Trial Details

Trial ID

NCT00726349

Start Date

May 1 2008

End Date

May 1 2011

Last Update

May 5 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHUM-Hôpital Notre-Dame

Montreal, Quebec, Canada, H2L 4M1

Transfusion Requirements in Orthopedic Surgery (PHASE 2) | DecenTrialz